JP2011251968A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011251968A5 JP2011251968A5 JP2011138608A JP2011138608A JP2011251968A5 JP 2011251968 A5 JP2011251968 A5 JP 2011251968A5 JP 2011138608 A JP2011138608 A JP 2011138608A JP 2011138608 A JP2011138608 A JP 2011138608A JP 2011251968 A5 JP2011251968 A5 JP 2011251968A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutical composition
- composition according
- pivaloyl
- mesylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C(C1)[C@@](CO*)O[C@@]1N(C=C(C(*)=N1)F)C1=O Chemical compound *C(C1)[C@@](CO*)O[C@@]1N(C=C(C(*)=N1)F)C1=O 0.000 description 2
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10717898P | 1998-11-05 | 1998-11-05 | |
| US60/107,178 | 1998-11-05 | ||
| US11586299P | 1999-01-13 | 1999-01-13 | |
| US60/115,862 | 1999-01-13 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000579239A Division JP2002528510A (ja) | 1998-11-05 | 1999-11-05 | ＨＩＶ感染の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011251968A JP2011251968A (ja) | 2011-12-15 |
| JP2011251968A5 true JP2011251968A5 (enExample) | 2012-09-06 |
Family
ID=26804484
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000579239A Withdrawn JP2002528510A (ja) | 1998-11-05 | 1999-11-05 | ＨＩＶ感染の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド |
| JP2011138608A Pending JP2011251968A (ja) | 1998-11-05 | 2011-06-22 | ＨＩＶ感染の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000579239A Withdrawn JP2002528510A (ja) | 1998-11-05 | 1999-11-05 | ＨＩＶ感染の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1124565B1 (enExample) |
| JP (2) | JP2002528510A (enExample) |
| KR (1) | KR100679239B1 (enExample) |
| AT (1) | ATE321561T1 (enExample) |
| AU (1) | AU768059B2 (enExample) |
| BR (1) | BR9915037A (enExample) |
| CA (1) | CA2348948C (enExample) |
| DE (1) | DE69930678T2 (enExample) |
| ES (1) | ES2262366T3 (enExample) |
| IL (2) | IL142982A0 (enExample) |
| MX (1) | MXPA01004505A (enExample) |
| WO (1) | WO2000025799A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| PL359169A1 (en) | 2000-05-26 | 2004-08-23 | Idenix (Cayman) Limited | Methods and compositions for treating flaviviruses and pestiviruses |
| CN101172993A (zh) | 2002-06-28 | 2008-05-07 | 埃迪尼克斯(开曼)有限公司 | 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷 |
| KR20050035194A (ko) | 2002-06-28 | 2005-04-15 | 이데닉스 (케이만) 리미티드 | 플라비비리다에 감염 치료용 2'-ｃ-메틸-3'-ｏ-ｌ-발린에스테르 리보푸라노실 사이티딘 |
| AU2003298658A1 (en) | 2002-11-15 | 2004-06-15 | Idenix (Cayman) Limited | 2'-branched nucleosides and flaviviridae mutation |
| US7598373B2 (en) | 2002-12-12 | 2009-10-06 | Idenix Pharmaceuticals, Inc. | Process for the production of 2-C-methyl-D-ribonolactone |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD293498A5 (de) * | 1989-07-20 | 1991-09-05 | Zi Fuer Molekularbiologie Der Adw,De | Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier |
| AU7954694A (en) * | 1993-09-10 | 1995-03-27 | Centre National De La Recherche Scientifique (Cnrs) | Nucleosides with anti-hepatitis b virus activity |
| BR9610120A (pt) * | 1995-09-07 | 1999-12-21 | Univ Georgia Res Found | Composição farmacêutica e processo para aumentar a meia vida de um medicamento em um indivìduo e para melhorar uma condição patológica em um paciente. |
| SK284054B6 (sk) * | 1996-10-16 | 2004-08-03 | Icn Pharmaceuticals, Inc. | Substituované triazolové nukleozidy, farmaceutický prostriedok s ich obsahom a ich použitie |
-
1999
- 1999-11-05 WO PCT/US1999/026156 patent/WO2000025799A1/en not_active Ceased
- 1999-11-05 ES ES99971324T patent/ES2262366T3/es not_active Expired - Lifetime
- 1999-11-05 AT AT99971324T patent/ATE321561T1/de not_active IP Right Cessation
- 1999-11-05 KR KR1020017005695A patent/KR100679239B1/ko not_active Expired - Fee Related
- 1999-11-05 EP EP99971324A patent/EP1124565B1/en not_active Expired - Lifetime
- 1999-11-05 IL IL14298299A patent/IL142982A0/xx unknown
- 1999-11-05 MX MXPA01004505A patent/MXPA01004505A/es active IP Right Grant
- 1999-11-05 DE DE69930678T patent/DE69930678T2/de not_active Expired - Lifetime
- 1999-11-05 CA CA002348948A patent/CA2348948C/en not_active Expired - Fee Related
- 1999-11-05 JP JP2000579239A patent/JP2002528510A/ja not_active Withdrawn
- 1999-11-05 AU AU14691/00A patent/AU768059B2/en not_active Ceased
- 1999-11-05 BR BR9915037-9A patent/BR9915037A/pt not_active IP Right Cessation
-
2001
- 2001-05-04 IL IL142982A patent/IL142982A/en not_active IP Right Cessation
-
2011
- 2011-06-22 JP JP2011138608A patent/JP2011251968A/ja active Pending